Outcome of distal gastric cancer with pyloric stenosis after curative resection

被引:31
作者
Chen, J.-H.
Wu, C.-W.
Lo, S.-S.
Li, A. F.-Y.
Hsieh, M.-C.
Shen, K.-H.
Lui, W.-Y
机构
[1] Vet Gen Hosp, Dept Surg, Taipei 11217, Taiwan
[2] Natl Yang Ming Univ, Taipei 11217, Taiwan
[3] Vet Gen Hosp, Dept Pathol, Taipei 11217, Taiwan
来源
EJSO | 2007年 / 33卷 / 05期
关键词
distal third gastric cancer; pyloric stenosis; curative resection;
D O I
10.1016/j.ejso.2007.01.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Pyloric stenosis usually presents with symptoms, and this may lead patients to consult their physician. We evaluate whether distal gastric cancer patients with pyloric stenosis had a better outcome than those without. Methods: A total of 551 distal gastric cancer patients who received curative subtotal gastrectomy between January 1988 and December 2003 at Taipei Veterans General Hospital were analyzed. Among them, 174 patients were sorted into the pyloric stenosis group according to obstructive symptoms. Their clinicopathological features, survival and prognostic factors were evaluated. Results:. The 5-year overall and disease-free survival rate of distal third gastric adenocarcinoma for the pyloric stenosis group was significantly lower than those without pyloric stenosis. Multivariate analysis revealed the pyloric stenosis group had deeper cancer invasion (relative to pT(1), RR of pT(2) 3.1, p=0.009; pT(3) 6.1, p<0.001; pT(4) 16.5, p<0.001), and more lymph node metastasis (RR 3.6; p=0.001). The pyloric stenosis group had a tendency to lymph node metastasis toward the hepatoduodenal ligament, but this did not reach statistical difference. However, the pyloric stenosis group had significantly higher lymph node metastasis in the retropancreatic region (5.17% vs. 0.53%; p=0.001). Conclusions: Distal gastric cancers with pyloric stenosis have worse biological behavior than those without, and consequently have a poor outcome. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:556 / 560
页数:5
相关论文
共 16 条
[1]  
Adachi Y, 1997, J AM COLL SURGEONS, V184, P373
[2]  
Bruno L, 2000, J SURG ONCOL, V74, P30, DOI 10.1002/1096-9098(200005)74:1<30::AID-JSO7>3.3.CO
[3]  
2-U
[4]   Epidemiology of upper gastrointestinal malignancies [J].
Crew, KD ;
Neugut, AI .
SEMINARS IN ONCOLOGY, 2004, 31 (04) :450-464
[5]  
Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10
[6]   p53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer [J].
Kanai, T ;
Konno, H ;
Maruyama, K ;
Baba, M ;
Tanaka, T ;
Maruo, Y ;
Nishino, N ;
Nakamura, S ;
Baba, S ;
Sugimura, H .
EUROPEAN SURGICAL RESEARCH, 1997, 29 (01) :35-41
[7]   Biologic predictors of survival in node-negative gastric cancer [J].
Kooby, DA ;
Suriawinata, A ;
Klimstra, DS ;
Brennan, MF ;
Karpeh, MS .
ANNALS OF SURGERY, 2003, 237 (06) :828-837
[8]   Surgical treatment and outcome for node-negative gastric cancer [J].
Maehara, Y ;
Tomoda, M ;
Tomisaki, S ;
Ohmori, M ;
Baba, H ;
Akazawa, K ;
Sugimachi, K .
SURGERY, 1997, 121 (06) :633-639
[10]   Gastric carcinoma with pyloric stenosis [J].
Watanabe, A ;
Maehara, Y ;
Okuyama, T ;
Kakeji, Y ;
Korenaga, D ;
Sugimachi, K .
SURGERY, 1998, 123 (03) :330-334